Fig. 3.
Occurrence of treatment failures and prostate-specific antigen (PSA)-related indices over time in 186 patients treated with EBRT combined with BT boost and ADT for localized prostate cancer
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.